Invasive fungal infections in a paediatric intensive care unit in a lower- middle-income country
Article Sidebar
Main Article Content
Abstract
Background. Paediatric intensive care units (PICUs) are high-risk settings for healthcare-associated infections. Invasive fungal infection (IFI) is one of the common causes of healthcare-associated infections.
Objective. To describe the prevalence and short-term outcomes of children with IFI, and to offer a basis for the efficient prevention and treatment of IFI.
Methods. A retrospective study was conducted in children under the age of 12 years over a two-year period. Participants were categorised according to pre-defined microbiology criteria into IFI if they had a positive culture from blood or other sterile sites. Data collected included demographics, invasive procedures, length of stay and mortality.
Results. One thousand and forty-two children were admitted during the study period. Of the total, 56.8% (n = 592) were male. Median length of stay was 18 days (mean ± SE 18.6±8.9). IFI was identified in 35 cases per 1 000 admissions, with 77.7% of these infants under the age of one year. The mean length of stay was 18.6 days compared with 7.5 days for children with bacterial infections. The in-hospital mortality for invasive fungal infection was 36% compared with 16% for all admissions. Findings confirmed that colonisation was more prevalent than IFI.
Conclusion. IFIs are common among infants, and these patients have a higher mortality rate and prolonged hospital stay. Therefore we recommend early diagnosis and timely treatment with high-performance antifungal drugs to improve the prognosis in children with IFI. Keywords. Healthcare-associated infections, South Africa, neonates, mortality, sepsis.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Zingg W, Hopkins S, Gayet-Ageron A, Holmes A, Sharland M, Suetens C. Health-care- associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey. Lancet Infect Dis 2017;17(4):381-389. https://doi.org/10.1016/s1473-3099(16)30517-5
Dramowski A, Cotton MF, Whitelaw A. Surveillance of healthcare-associated infection in hospitalised South African children: Which method performs best? S Afr Med J 2016;107(1):56-63. https://doi.org/10.7196/samj.2016.v107.i1.11431
Spicer KB, Green J, Dhada B. Hospital-acquired infections in paediatric medical wards at a tertiary hospital in KwaZulu-Natal, South Africa. Paediatr Int Child Health 2018;38(1):53-59. https://doi.org/10.1080/20469047.2017.1299897
Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999;103(4):e39. https://doi.org/10.1542/peds.103.4.e39
Bajwa S, Kulshrestha A. Fungal infections in intensive care unit: Challenges in diagnosis and management. Ann Med Health Sci Res 2013;3(2):238-244. https://doi. org/10.4103%2F2141-9248.113669
Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 2010;51(5):e38-45. https://doi.org/10.1086/655698
Brissaud O, Guichoux J, Harambat J, Tandonnet O, Zaoutis T. Invasive fungal disease in PICU: Epidemiology and risk factors. Ann Intensive Care 2012;2(1):6. https://doi. org/10.1186/2110-5820-2-6
ChowJK,GolanY,RuthazerR,etal.Factorsassociatedwithcandidemiacausedbynon- albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008;46(8):1206-1213. https://doi.org/10.1086/529435
Kumar S, Singhi S, Chakrabarti A, Bansal A, Jayashree M. Probiotic use and prevalence of candidemia and candiduria in a PICU. Pediatr Crit Care Med 2013;14(9):e409-415. https://doi.org/10.1097/pcc.0b013e31829f5d88
Manzoni P, Farina D, Leonessa M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonisation. Pediatrics 2006;118(6):2359- 2364. https://doi.org/10.1542/peds.2006-1311
Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalised in the United States: A propensity analysis. Clin Infect Dis 2005;41(9):1232-1239. https://doi. org/10.1086/496922
Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag 2014;10:95-105. https://doi.org/10.2147/tcrm.s40160
Singhi S, Rao DS, Chakrabarti A. Candida colonisation and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2008;9(1):91-95. https://doi.org/10.1097/01.pcc.0000298643.48547.83
Filioti J, Spiroglou K, Roilides E. Invasive candidiasis in pediatric intensive care patients: Epidemiology, risk factors, management, and outcome. Intensive Care Med 2007;33(7):1272-1283. https://doi.org/10.1007/s00134-007-0672-5
Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T. Epidemiology of invasive fungal disease in children. J Pediatr Infect Dis Soc 2017;6(suppl 1):S3-S11. https://doi. org/10.1093/jpids/pix046
Hirano R, Sakamoto Y, Kudo K, Ohnishi M. Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: A single hospital experience. Infect Drug Resist 2015;8:199-205. https://doi.org/10.2147/idr.s80677
Arslankoylu AE, Kuyucu N, Yilmaz BS, Erdogan S. Symptomatic and asymptomatic candidiasis in a pediatric intensive care unit. Ital J Pediatr 2011;37:56. https://doi. org/10.1186%2F1824-7288-37-56
Menzin J, Meyers JL, Friedman M, et al. Mortality, length of hospitalisation, and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm 2009;66(19):1711-1717. https://doi.org/10.2146/ajhp080325